Does CLOPIDOGREL BISULFATE Cause Coronary revascularisation? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Coronary revascularisation have been filed in association with CLOPIDOGREL BISULFATE (Clopidogrel). This represents 0.0% of all adverse event reports for CLOPIDOGREL BISULFATE.
14
Reports of Coronary revascularisation with CLOPIDOGREL BISULFATE
0.0%
of all CLOPIDOGREL BISULFATE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Coronary revascularisation From CLOPIDOGREL BISULFATE?
Of the 14 reports, 8 (57.1%) required hospitalization.
Is Coronary revascularisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOPIDOGREL BISULFATE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CLOPIDOGREL BISULFATE Cause?
Gastrointestinal haemorrhage (5,513)
Anaemia (3,043)
Dyspnoea (1,963)
Drug interaction (1,846)
Haemorrhage (1,762)
Drug ineffective (1,644)
Cerebral haemorrhage (1,603)
Dizziness (1,586)
Epistaxis (1,560)
Melaena (1,547)
What Other Drugs Cause Coronary revascularisation?
TIROFIBAN (21)
EVOLOCUMAB (14)
ASPIRIN (12)
AMLODIPINE\VALSARTAN (5)
ATORVASTATIN\EZETIMIBE (5)
NEBIVOLOL (5)
Which CLOPIDOGREL BISULFATE Alternatives Have Lower Coronary revascularisation Risk?
CLOPIDOGREL BISULFATE vs CLORAZEPATE
CLOPIDOGREL BISULFATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN
CLOPIDOGREL BISULFATE vs CLOTHIAPINE
CLOPIDOGREL BISULFATE vs CLOTIAZEPAM
CLOPIDOGREL BISULFATE vs CLOTRIMAZOLE